Application Note

Quantify Secreted T Cell Activation Markers

Source: bio-techne
bio Techne TCbuster

Although Chimeric Antigen Receptor (CAR) T cells have great therapeutic utility, the manufacturing workflow is complex and stringent regulatory requirements must be met. CAR T cells must be thoroughly characterized in vitro before infusion into the patient. Bio-Techne is pleased to offer Simple Plex T Cell activation marker assays to support cell therapy development and manufacturing scientists. Simple Plex assays on the Ella platform offer a rapid and precise assessment of secreted T cell activation markers to boost cell therapy development and manufacturing efficiency.

In this application note, we use TcBuster™, Bio-Techne’s novel non-viral gene delivery technology, to generate CD19 CAR T cells and validate the use of Ella as a T Cell activation marker assay platform. Read on to learn more.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online